Zydus Lifesciences Limited (NSE:ZYDUSLIFE)
India
· Delayed Price · Currency is INR | Market Cap | 827.22B |
| Revenue (ttm) | 222.47B |
| Net Income (ttm) | 45.37B |
| Shares Out | 1.01B |
| EPS (ttm) | 45.03 |
| PE Ratio | 18.27 |
| Forward PE | 17.60 |
| Dividend | 3.00 (0.34%) |
| Ex-Dividend Date | Jul 26, 2024 |
| Volume | 10,250,217 |
| Average Volume | 2,197,712 |
| Open | 883.15 |
| Previous Close | 883.15 |
| Day's Range | 813.00 - 887.25 |
| 52-Week Range | 795.00 - 1,324.30 |
| Beta | 0.56 |
| RSI | 36.64 |
| Earnings Date | May 16, 2025 |
About Zydus Lifesciences
Zydus Lifesciences Limited engages in the research, development, production, marketing, distribution, and sale of pharmaceutical products in India, the United States, and internationally. It operates through two segments: Pharmaceuticals and Consumer Products. It offers finished dosage human formulations, such as generics; branded generics; specialty formulations, including biosimilars and vaccines; active pharmaceutical ingredients; consumer wellness products; animal healthcare products; and products in the therapeutic areas of pain management... [Read more]
Financial Performance
In 2023, Zydus Lifesciences's revenue was 195.47 billion, an increase of 13.40% compared to the previous year's 172.37 billion. Earnings were 38.60 billion, an increase of 96.88%.
Financial StatementsNews
Zydus down 5%, Lupin down nearly 4% as US court orders withdrawal of Myrbetriq drug
Shares of Zydus Lifesciences and Lupin plunged sharply on April 16 after both companies lost a patent litigation case related to the bladder treatment drug Myrbetriq in the United States. The US Feder...
Zydus Lifesciences shares drop over 2.5% after losing Myrbetriq patent case in US
Shares of Zydus Lifesciences Ltd fell sharply by 2.63% to ₹859.95 during Tuesday’s trade following a major legal setback in the US. The stock dropped from a previous close of ₹883.15, reacting negativ...
Stocks to watch today: Zydus, Aurobindo, HCL Tech, Tata Power, Indian Hotels, Cyient in focus on expansion and global deals
Stocks of several companies are expected to remain in the spotlight today following a series of announcements related to international expansion, regulatory approvals, and strategic partnerships. Zydu...
Top Stocks to watch on April 15: Ircon, Zydus, Ashoka Buildcon, Tata Power, Macrotech, Cyient in focus as markets reopen after long weekend
Indian stock markets reopen after the Monday holiday (April 14) for Dr. Baba Saheb Ambedkar Jayanti. Here are the key stocks to watch: Ircon International Secured a Letter of Acceptance worth ₹127 cro...
Zydus Lifesciences receives USFDA approval for Jaythari (Deflazacort) Tablets across four strengths
Zydus Lifesciences Limited has announced that it has received final approval from the United States Food and Drug Administration (USFDA) to manufacture and market its Jaythari® (Deflazacort) tablets i...
Pharma Stocks Falls: Aurobindo Pharma slips 2%, Lupin down 2%, Divi’s Labs falls 3% as Trump reiterates tariffs on pharmaceuticals ‘soon’
Indian pharmaceutical stocks declined in early trade on Wednesday following renewed concerns over potential U.S. import tariffs. At 9:36 AM, Aurobindo Pharma shares were down 2% to ₹1,073.15, Dr. Redd...
Zydus Lifesciences shares fall nearly 7% as Trump signals potential pharma tariffs
Shares of Zydus Lifesciences Ltd declined 6.92% to ₹839.50 on Friday, falling ₹62.40 from the previous close of ₹901.90, as concerns escalated over the potential imposition of U.S. tariffs on pharmace...
Zydus Lifesciences shares jump 5.25% as U.S. spares pharma exports from 26% tariff
Shares of Zydus Lifesciences Ltd surged 5.25% to ₹937.95 on April 3, emerging as one of the top gainers in early trade, after U.S. President Donald Trump’s reciprocal tariff policy excluded pharmaceut...
Top stocks to buy today: Stock recommendations for March 21, 2025
Stock market recommendations: Bajaj Broking Research recommends Zydus Lifesciences and National Aluminium stocks for today. It expects Nifty to move towards 23,500 levels and sees Bank Nifty heading t...
Zydus shares nearly jump 3% on USFDA approval for Apalutamide Tablets
Zydus Lifesciences Ltd saw nearly 3% surge in its stock price after securing final approval from the U.S. Food and Drug Administration (USFDA) to manufacture and market Apalutamide Tablets, 60 mg, in ...
Zydus receives U.S. FDA nod for 60 mg Apalutamide Tablets
Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration (USFDA) to manufacture and market Apalutamide Tablets, 60 mg (Erleada® Tablets, 60 mg) in the...
Zydus Lifesciences shares up 2% as USFDA grants approval for Eluxadoline tablets
Shares of Zydus Lifesciences Ltd (NSE:ZYDU) surged 2% after the company received final approval from the U.S. Food and Drug Administration (USFDA) to manufacture and market Eluxadoline Tablets (75 mg ...
Top stocks to watch today, March 17: IndusInd Bank, Ola Electric, Tata Motors, Zydus Lifesciences and more
The Indian stock markets resume trading on March 17 after a three-day break, following a weak closing in the previous session. On March 13, the S&P BSE Sensex fell by 200.85 points to settle at 73,828...
Zydus Lifesciences’ Ankleshwar API unit clears USFDA inspection with zero observations
Zydus Lifesciences Ltd announced that the US Food and Drug Administration (USFDA) has successfully concluded a surveillance inspection at its Active Pharmaceutical Ingredient (API) Unit 1 in Ankleshwa...
Zydus receives USFDA approval for Methenamine Hippurate Tablets USP, 1 gram
Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration (USFDA) to manufacture and market Methenamine Hippurate Tablets USP, 1 gram (generic version ...
Zydus Life in negotiations to buy French medtech firm
Zydus Lifesciences announced it is negotiating to acquire a majority stake in French medtech firm Amplitude Surgical for approximately Rs 2,500 crore. The acquisition aims to boost Zydus's global medt...
Zydus Lifesciences to acquire 85.6% stake in Amplitude Surgical SA for €256.8 million
Zydus Lifesciences Limited has announced its acquisition of an 85.6% controlling stake in Amplitude Surgical SA, a leading French MedTech company specializing in orthopedic solutions. This strategic m...
Zydus gets USFDA final approval for Ketoconazole Shampoo, 2%
Zydus Lifesciences Limited has secured final approval from the United States Food and Drug Administration (USFDA) to manufacture and market Ketoconazole Shampoo, 2% (a generic version of Nizoral® Sham...
Zydus Lifesciences shares surge over 4% after USFDA approval for generic Dasatinib tablets
Shares of Zydus Lifesciences Ltd (NSE: ZYDUSLIFE) jumped 4.11% to ₹923.90 on March 6, 2025, after the company received final approval from the United States Food and Drug Administration (USFDA) to man...
Stocks to watch today, March 6: Zydus Lifesciences, Castrol India, TCS, Wipro, Ola Electric and more
The Indian stock market saw a significant rebound on Wednesday (March 5), as benchmark indices surged following value buying in utilities, power stocks, and a positive global market trend. The BSE Sen...
Zydus Lifesciences secures USFDA approval for Dasatinib Tablets
Zydus Lifesciences Limited has received final approval from the U.S. Food and Drug Administration (USFDA) to manufacture Dasatinib Tablets in multiple strengths—20 mg, 50 mg, 70 mg, 80 mg, 100 mg, and...
Zydus Lifesciences launches ANVIMO for transplant patients
Zydus Lifesciences, a global leader in innovation-driven healthcare, has introduced ANVIMO (Letermovir) in India, a groundbreaking advancement in the prevention of Cytomegalovirus (CMV) infection for ...
Zydus To Develop Combination Vaccine For Shigellosis And Typhoid
Zydus Lifesciences on Tuesday said it will undertake development of a combination vaccine against shigellosis and typhoid.
Zydus Lifesciences to develops world’s first shigellosis and typhoid combination vaccine
Zydus Lifesciences Limited, a global leader in life sciences and vaccine innovation, has announced its groundbreaking project to develop the world’s first combination vaccine against typhoid and shige...
Zydus gets USFDA nod for Ibuprofen and Famotidine tablets
Zydus Lifesciences Limited has recently informed exchanges that the company received final approval from the United States Food and Drug Administration (USFDA) to manufacture and market Ibuprofen and ...